- Home
- DGICA vs QDEL Comparison
DGICA vs QDEL Comparison
Compare DGICA & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DGICA | QDEL |
|---|---|---|
| Founded | 1986 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 705.0M | 1.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DGICA | QDEL |
|---|---|---|
| Price | $20.27 | $28.79 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 6 |
| Target Price | $18.00 | ★ $39.33 |
| AVG Volume (30 Days) | 116.0K | ★ 1.1M |
| Earning Date | 10-30-2025 | 11-05-2025 |
| Dividend Yield | ★ 3.58% | N/A |
| EPS Growth | ★ 219.91 | N/A |
| EPS | ★ 2.38 | N/A |
| Revenue | $987,826,105.00 | ★ $2,714,400,000.00 |
| Revenue This Year | $2.26 | N/A |
| Revenue Next Year | $3.46 | $2.42 |
| P/E Ratio | $8.55 | ★ N/A |
| Revenue Growth | ★ 0.89 | N/A |
| 52 Week Low | $14.17 | $19.50 |
| 52 Week High | $21.12 | $49.45 |
Technical Indicators
Market Signals| Indicator | DGICA | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 60.99 | 60.76 |
| Support Level | $19.40 | $26.84 |
| Resistance Level | $20.45 | $30.40 |
| Average True Range (ATR) | 0.51 | 1.23 |
| MACD | 0.02 | 0.44 |
| Stochastic Oscillator | 80.60 | 76.13 |
Price Performance
Historical ComparisonAbout DGICA Donegal Group Inc.
Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.